APRI score non-invasive marker of metabolic syndrome in breast carcinoma patients

ConclusionAPRI score can be used as a surrogate marker of metabolic syndrome in patients with breast carcinoma. It is also useful in planning preventive strategies in patients with breast carcinoma especially in post-menopausal age group.
Source: Clinical Epidemiology and Global Health - Category: Epidemiology Source Type: research